| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5960056 | Heart Rhythm | 2015 | 23 Pages |
Abstract
No dose of ranolazine significantly prolonged time to AF recurrence. However, the 500-mg and 750 mg-groups combined reduced AF recurrences, suggesting a possible role for this agent in the treatment of AF.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gaetano M. MD, Lars S. MD, LluÃs MD, PhD, Peter J. MD, FAHA, FHRS, Gregor MD, Matthias MD, Edoardo MD, Giuseppe MD, PhD, Harald MD, Laura MD, Irene MD, PhD, Veronica MD, Niccolò MD, Miguel MD, PhD, Kai MD, Giulia PhD, Lorenzo MD, PhD, Stefano MD,